SG11201705138QA - Aqueous ophthalmic solution - Google Patents
Aqueous ophthalmic solutionInfo
- Publication number
- SG11201705138QA SG11201705138QA SG11201705138QA SG11201705138QA SG11201705138QA SG 11201705138Q A SG11201705138Q A SG 11201705138QA SG 11201705138Q A SG11201705138Q A SG 11201705138QA SG 11201705138Q A SG11201705138Q A SG 11201705138QA SG 11201705138Q A SG11201705138Q A SG 11201705138QA
- Authority
- SG
- Singapore
- Prior art keywords
- ophthalmic solution
- aqueous ophthalmic
- aqueous
- solution
- ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C13/00—Assembling; Repairing; Cleaning
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014263003 | 2014-12-25 | ||
| JP2015114595 | 2015-06-05 | ||
| PCT/JP2015/086230 WO2016104704A1 (en) | 2014-12-25 | 2015-12-25 | Aqueous ophthalmic solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201705138QA true SG11201705138QA (en) | 2017-07-28 |
Family
ID=56150716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201705138QA SG11201705138QA (en) | 2014-12-25 | 2015-12-25 | Aqueous ophthalmic solution |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10278985B2 (en) |
| JP (3) | JP6779614B2 (en) |
| KR (3) | KR101867791B1 (en) |
| AR (1) | AR105199A1 (en) |
| BR (1) | BR112017013841A2 (en) |
| CA (1) | CA2971689C (en) |
| EA (1) | EA034517B1 (en) |
| MX (1) | MX2017008277A (en) |
| MY (1) | MY182507A (en) |
| PH (1) | PH12017501096A1 (en) |
| SG (1) | SG11201705138QA (en) |
| TW (1) | TWI709405B (en) |
| WO (1) | WO2016104704A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY182507A (en) * | 2014-12-25 | 2021-01-25 | Santen Pharmaceutical Co Ltd | Aqueous ophthalmic solution |
| JP6104433B2 (en) * | 2015-06-05 | 2017-03-29 | 参天製薬株式会社 | Aqueous ophthalmic solution |
| KR20180014768A (en) | 2015-06-05 | 2018-02-09 | 산텐 세이야꾸 가부시키가이샤 | Characterized in that the soft contact lens is applied to the eyes of a dry eye patient wearing a dry contact lens |
| EA202092030A1 (en) | 2018-02-28 | 2020-11-16 | Сантен Фармасьютикал Ко., Лтд. | OPHTHALMIC COMPOSITION INCLUDING DYQUAPHOSOL AND CATION POLYMER |
| TW202122094A (en) * | 2019-08-27 | 2021-06-16 | 日商參天製藥股份有限公司 | Diquafosol or salt thereof, and aqueous ophthalmic composition containing polyvinylpyrrolidone |
| US11229549B2 (en) * | 2019-09-18 | 2022-01-25 | Vance M. Thompson | Tear transplantation and multi-part contact lens with absorbent portion |
| CN115996705A (en) * | 2020-06-23 | 2023-04-21 | 株式会社泰俊制药 | Ophthalmic compositions comprising diquafosol |
| KR102365008B1 (en) * | 2020-06-23 | 2022-02-23 | 주식회사태준제약 | Ophthalmic Composition Comprising Diquafosol |
| KR102548710B1 (en) | 2020-12-24 | 2023-06-28 | 주식회사 종근당 | Pharmaceutical composition for prevention or treatment of dry eye syndrome comprising diquafosol or pharmaceutically acceptable salts thereof and tocopherol |
| JP7230169B2 (en) * | 2020-12-25 | 2023-02-28 | 参天製薬株式会社 | Aqueous ophthalmic solution containing diquafosol or its salt, silver salt and ionic tonicity agent |
| WO2024010040A1 (en) * | 2022-07-06 | 2024-01-11 | ロート製薬株式会社 | Ophthalmic composition |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09301858A (en) | 1996-05-13 | 1997-11-25 | Senju Pharmaceut Co Ltd | Aqueous medicine containing stabilized cholorohexidine gluconate |
| JPH10203960A (en) * | 1997-01-24 | 1998-08-04 | Ofutekusu:Kk | Eye lotion composition |
| JPH1160505A (en) | 1997-05-20 | 1999-03-02 | Senju Pharmaceut Co Ltd | Antiseptic composition |
| JP2008222638A (en) | 2007-03-13 | 2008-09-25 | Teika Seiyaku Kk | Oil component-containing ophthalmic composition |
| JP2009073788A (en) | 2007-09-21 | 2009-04-09 | Teika Seiyaku Kk | Isopropyl unoprostone-containing ophthalmic composition |
| JP5398452B2 (en) * | 2008-09-30 | 2014-01-29 | 大正製薬株式会社 | Eye drops |
| WO2011016562A1 (en) * | 2009-08-07 | 2011-02-10 | ロート製薬株式会社 | Ophthalmic composition for silicone hydrogel contact lens |
| JP6047272B2 (en) | 2010-09-15 | 2016-12-21 | テイカ製薬株式会社 | Eye drops for treatment of corneal epithelial disorder |
| UA113839C2 (en) * | 2010-12-28 | 2017-03-27 | EYE SOLUTION CONTAINING DICVAFOSOL, METHOD OF ITS PREPARATION AND METHOD OF INHIBITION OF NON-SOLUTION DEPOSIT | |
| TWI757799B (en) * | 2012-03-26 | 2022-03-11 | 日商參天製藥股份有限公司 | Manufacturing method of aqueous ophthalmic solution |
| MY182507A (en) * | 2014-12-25 | 2021-01-25 | Santen Pharmaceutical Co Ltd | Aqueous ophthalmic solution |
-
2015
- 2015-12-25 MY MYPI2017000969A patent/MY182507A/en unknown
- 2015-12-25 EA EA201791467A patent/EA034517B1/en not_active IP Right Cessation
- 2015-12-25 KR KR1020177029478A patent/KR101867791B1/en active IP Right Grant
- 2015-12-25 US US15/539,283 patent/US10278985B2/en active Active
- 2015-12-25 KR KR1020177014598A patent/KR101789019B1/en active IP Right Grant
- 2015-12-25 JP JP2015253360A patent/JP6779614B2/en active Active
- 2015-12-25 WO PCT/JP2015/086230 patent/WO2016104704A1/en active Application Filing
- 2015-12-25 TW TW104143787A patent/TWI709405B/en active
- 2015-12-25 CA CA2971689A patent/CA2971689C/en active Active
- 2015-12-25 SG SG11201705138QA patent/SG11201705138QA/en unknown
- 2015-12-25 BR BR112017013841-7A patent/BR112017013841A2/en not_active Application Discontinuation
- 2015-12-25 KR KR1020187015734A patent/KR102330736B1/en active IP Right Grant
- 2015-12-25 MX MX2017008277A patent/MX2017008277A/en unknown
-
2016
- 2016-06-29 AR ARP160101981A patent/AR105199A1/en unknown
-
2017
- 2017-06-13 PH PH12017501096A patent/PH12017501096A1/en unknown
-
2019
- 2019-03-13 US US16/351,661 patent/US10786526B2/en active Active
-
2020
- 2020-10-14 JP JP2020173120A patent/JP7128243B2/en active Active
-
2022
- 2022-08-18 JP JP2022130503A patent/JP2022166223A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20180063381A (en) | 2018-06-11 |
| AR105199A1 (en) | 2017-09-13 |
| WO2016104704A1 (en) | 2016-06-30 |
| CA2971689C (en) | 2020-11-03 |
| KR102330736B1 (en) | 2021-11-23 |
| TWI709405B (en) | 2020-11-11 |
| JP7128243B2 (en) | 2022-08-30 |
| PH12017501096A1 (en) | 2017-11-27 |
| CA2971689A1 (en) | 2016-06-30 |
| KR20170118255A (en) | 2017-10-24 |
| KR20170067900A (en) | 2017-06-16 |
| EA201791467A1 (en) | 2017-11-30 |
| TW201628626A (en) | 2016-08-16 |
| EA034517B1 (en) | 2020-02-17 |
| MY182507A (en) | 2021-01-25 |
| JP2021008513A (en) | 2021-01-28 |
| MX2017008277A (en) | 2017-10-02 |
| KR101867791B1 (en) | 2018-06-15 |
| US20170348344A1 (en) | 2017-12-07 |
| US10278985B2 (en) | 2019-05-07 |
| BR112017013841A2 (en) | 2018-06-19 |
| JP6779614B2 (en) | 2020-11-04 |
| JP2022166223A (en) | 2022-11-01 |
| US10786526B2 (en) | 2020-09-29 |
| KR101789019B1 (en) | 2017-10-20 |
| JP2016210759A (en) | 2016-12-15 |
| US20190209599A1 (en) | 2019-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL249643A0 (en) | Ophthalmic composition | |
| GB201419865D0 (en) | Solution | |
| HK1244689A1 (en) | Aqueous ophthalmic composition | |
| SG11201506309SA (en) | Eye massager | |
| PT3206678T (en) | Body sculpting | |
| SG11201705138QA (en) | Aqueous ophthalmic solution | |
| EP3209331C0 (en) | Ophthalmic solution | |
| EP3110903A4 (en) | Aqueous solution and methods for manufacture and use | |
| HK1205924A1 (en) | Eye massager | |
| SG11201704737SA (en) | Novel aqueous composition | |
| IL250017A0 (en) | Ophthalmoscopes | |
| ZA201605363B (en) | Goggles | |
| SG11201704740WA (en) | Aqueous composition | |
| IL248773A0 (en) | Naphthyridinedione derivatives | |
| LT3216451T (en) | Ophthalmic aqueous composition | |
| AP2016009530A0 (en) | Cycloalkyl-linked diheterocycle derivatives | |
| SG11201702202UA (en) | Aqueous composition | |
| PL3193833T3 (en) | Dialysis solution | |
| GB201401190D0 (en) | Spectacles | |
| ZA201703701B (en) | Ophthalmic composition | |
| IL251096A0 (en) | Bromide removal from aqueous solutions | |
| EP3231427A4 (en) | Aqueous liquid agent | |
| GB201410046D0 (en) | Balayan sunglasses | |
| GB201420400D0 (en) | Janus eye | |
| TWM490587U (en) | Eyeglasses |